Key Takeaways from the Human Immunome Project Into Action Conference Just over a year ago, the Human Immunome Project (HIP) was initiated at a summit in La Jolla, California, drawing immunology leaders together to discuss the greatest challenge in the healthcare field. Since then we have introduced new leadership and new Board members, and launched…
Read More23andMe Founder Linda Avey Joins the Human Immunome Project Board of Directors
NEW YORK, November 30, 2023 – The Human Immunome Project (HIP) is pleased to announce the appointment of Linda Avey to the Board of Directors. “Linda’s scientific expertise and entrepreneurial spirit will be of immediate benefit to the Human Immunome Project as we pursue our mission to decode and model the human immune system,” said…
Read MoreScientific Consensus Builds on Effort to Map and Model Human Immune System
BARCELONA, November 21, 2023 – The Human Immunome Project Into Action Conference, hosted at CosmoCaixa Museum of Science by the CaixaResearch Institute and Human Immunome Project (HIP), concluded with agreement on a scientific strategy to map and model the human immune system, the groups announced today. The global effort, which will produce publicly available AI…
Read MoreActioning the Human Immunome Project
With a scientific plan now in place, the Human Immunome Project (HIP) is gearing up to begin implementation in early 2024. To set the stage, HIP, together with our partner CaixaResearch Institute, is hosting an “Into Action,” Conference to stress test the plan alongside global representatives from science, industry, government, and civil society, to agree…
Read MoreHIP 2.0: Unveiling Our Scientific Plan to Decode and Model the Immune System
At the Human Immunome Project, 2023 has been a year of great transition and progress. Learn how we plan to decode and model the immune system to transform the future of global health.
Read MoreInitiative to Decode Human Immune System Is the Talk of AI for Good Global Summit
GENEVA, July 6, 2023 — The Human Immunome Project’s (HIP) Board Chair Jane Metcalfe and CEO Hans Keirstead spoke today at the AI for Good Global Summit detailing how decoding and building an AI model of the immune system can revolutionize how we address disease and enable everyone to live longer, healthier lives.
Read MoreMichelson Prize Winners Collaborate on New, $9.5M Emerging Pathogens Project
Young researchers are often at the cutting-edge of scientific discovery, yet they struggle to find funding to support their efforts. The Michelson Prizes: Next Generation Grants are designed to fill this gap and reward young scientists pursuing innovative research to advance human immunology, vaccine discovery, and immunotherapy for global diseases. The grants, a partnership between…
Read MoreMeet Our New CEO: Dr. Hans Keirstead
The scientist and serial entrepreneur takes over the reigns of the Human Immunome Project, bringing decades of leadership and fundraising experience. Interview by Kristen Jill Abboud
Read MoreHuman Immunome Project Announces New Leadership
NEW YORK, MAY 22, 2023 — The Human Immunome Project has undertaken an internal restructuring to expand and accelerate its capacity to execute on the focused initiatives that serve health care stakeholders worldwide. As part of this restructuring, Founder Dr. Wayne Koff has retired from his full-time role as Chief Executive Officer. He will remain an…
Read More